Epigenetic therapy of non-small cell lung cancer using decitabine (5-aza-2'-deoxycytidine).
about
The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer CellsNovel epigenetic target therapy for prostate cancer: a preclinical studySFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancerA genome-wide search for epigenetically [corrected] regulated genes in zebra finch using MethylCap-seq and RNA-seqClinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis.γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?Novel Role for γ-Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1).Low concentrations of 5-aza-2'-deoxycytidine induce breast cancer stem cell differentiation by triggering tumor suppressor gene expression.Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers.Epigenetic modification of miR-141 regulates SKA2 by an endogenous 'sponge' HOTAIR in glioma.Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectives.Decitabine-based chemotherapy followed by haploidentical lymphocyte infusion improves the effectiveness in elderly patients with acute myeloid leukemiaThe role of DNA methylation in ST6Gal1 expression in gliomas.
P2860
Q27313466-11F2A921-39E4-4BB0-8494-AC0594CE00FBQ27330048-BB02B187-14C3-4E6D-A8E4-1ACF315AA626Q28277902-84B140D6-8236-4A61-9A0E-EFB6E8785EA6Q28600970-C049FF13-B08C-4360-B490-6574D39927F8Q35229048-0FD236E0-FFFE-4839-AF43-22E635195CCCQ35799192-A1508F92-A851-4F1D-B500-0A74E3F414B6Q35860664-5E0FC549-7F72-4C3E-A503-8C903E6029B7Q36412709-5FA79AB6-EE70-4DC1-BBA3-BC1D2499216FQ37162642-D6364EB9-B072-4F1B-983E-A341483F9B21Q37327566-E68FF6D3-0D39-40CB-9411-BA00476F19ACQ39009379-5E820287-FAA1-4157-9EFC-4EB0D76BF669Q41593326-CFC0FFC9-EC6D-447B-ABDC-1233219F2AB8Q51205890-9694E5B7-7823-4AD2-BD4B-758F07603310
P2860
Epigenetic therapy of non-small cell lung cancer using decitabine (5-aza-2'-deoxycytidine).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Epigenetic therapy of non-smal ...... bine (5-aza-2'-deoxycytidine).
@en
Epigenetic therapy of non-small cell lung cancer using decitabine
@nl
type
label
Epigenetic therapy of non-smal ...... bine (5-aza-2'-deoxycytidine).
@en
Epigenetic therapy of non-small cell lung cancer using decitabine
@nl
prefLabel
Epigenetic therapy of non-smal ...... bine (5-aza-2'-deoxycytidine).
@en
Epigenetic therapy of non-small cell lung cancer using decitabine
@nl
P2860
P356
P1476
Epigenetic therapy of non-smal ...... bine (5-aza-2'-deoxycytidine).
@en
P2093
Richard L Momparler
P2860
P356
10.3389/FONC.2013.00188
P577
2013-07-29T00:00:00Z